Phase I Study of <i>Ex Vivo</i>-Expanded Allogeneic Natural Killer Cells (MG4101) with Rituximab in Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
SSRN Electronic Journal(2022)
关键词
allogeneic natural killer cells,rituximab,b-cell,non-hodgkin
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要